Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones
Clinical trial NCT06982222 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06982222
- Sponsor
- National Cancer Institute (NCI)
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2027-02-12
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.